Experts worry insulin getting too expensive for many in U.S. and worldwide
Drugmakers have made great strides coming up with new treatments for diabetes as the disease gallops across the globe. However, healthcare professionals are concerned that hormone insulin meds, often the key treatment, are getting too costly for many patients, even in the U.S. In developing countries, they say engineered insulin is automatically out of reach of many people while supplies of older, but cheaper, human insulin are becoming scarce.